BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35384692)

  • 1. Dynamic Changes in Breast Milk Microbiome in the Early Postpartum Period of Kenyan Women Living with HIV Are Influenced by Antibiotics but Not Antiretrovirals.
    Maqsood R; Skidmore PT; Holland LA; Au JL; Khan AK; Wu LI; Ma N; Begnel ER; Chohan BH; Adhiambo J; John-Stewart G; Kiarie J; Kinuthia J; Chung MH; Richardson BA; Slyker J; Lehman DA; Lim ES
    Microbiol Spectr; 2022 Apr; 10(2):e0208021. PubMed ID: 35384692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.
    Minniear TD; Girde S; Angira F; Mills LA; Zeh C; Peters PJ; Masaba R; Lando R; Thomas TK; Taylor AW;
    PLoS One; 2014; 9(4):e93556. PubMed ID: 24733021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding.
    Grant-Beurmann S; Jumare J; Ndembi N; Matthew O; Shutt A; Omoigberale A; Martin OA; Fraser CM; Charurat M
    Microbiome; 2022 Apr; 10(1):61. PubMed ID: 35414043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Milk Virome and Bacterial Microbiome Resilience in Kenyan Women Living with HIV.
    Maqsood R; Reus JB; Wu LI; Holland LA; Nduati R; Mbori-Ngacha D; Maleche-Obimbo E; Begnel ER; Gantt S; Ojee E; Wamalwa D; John-Stewart G; Slyker J; Lehman DA; Lim ES
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33727396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
    Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission.
    Davis NL; Miller WC; Hudgens MG; Chasela CS; Sichali D; Kayira D; Nelson JA; Stringer JS; Ellington SR; Kourtis AP; Jamieson DJ; van der Horst C;
    AIDS; 2014 Nov; 28(18):2739-49. PubMed ID: 25493600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Highly Active Antiretroviral Therapy Reduces Vertical Cytomegalovirus Transmission But Does Not Reduce Breast Milk Cytomegalovirus Levels.
    Slyker JA; Richardson B; Chung MH; Atkinson C; Ásbjörnsdóttir KH; Lehman DA; Boeckh M; Emery V; Kiarie J; John-Stewart G
    AIDS Res Hum Retroviruses; 2017 Apr; 33(4):332-338. PubMed ID: 27796131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.
    Drake AL; Roxby AC; Kiarie J; Richardson BA; Wald A; John-Stewart G; Farquhar C
    PLoS One; 2012; 7(4):e34635. PubMed ID: 22509337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
    Lallemant M; Amzal B; Sripan P; Urien S; Cressey TR; Ngo-Giang-Huong N; Klinbuayaem V; Rawangban B; Sabsanong P; Siriwachirachai T; Jarupanich T; Kanjanavikai P; Wanasiri P; Koetsawang S; Jourdain G; Le Coeur S;
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):313-322. PubMed ID: 32205720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
    Fouché C; van Niekerk E; du Plessis LM
    Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
    Mirochnick M; Thomas T; Capparelli E; Zeh C; Holland D; Masaba R; Odhiambo P; Fowler MG; Weidle PJ; Thigpen MC
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1170-6. PubMed ID: 19114673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.